SCHEMBL20219489

SCHEMBL20219489

CCCCNc1nc(C)ncc1OCCCc1ccc(Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR8 Q9NR97 5/20 0.44
▸ TLR7 Q9NYK1 5/20 0.44
▸ STK17A Q9UEE5 5/20 0.41
▸ STK17B O94768 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ CRHR1 P34998 3/20 0.39
▸ MAPT P10636 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23472334 0.87 TLR8 (0.43) TLR8TLR7STK17ASTK17BKDM4E
SCHEMBL15469985 0.87 TLR8 (0.54) TLR8TLR7STK17ASTK17BL3MBTL1
SCHEMBL23472518 0.87 TLR7 (0.45) TLR8TLR7STK17ASMN1; SMN2
SCHEMBL20219479 0.84 TLR7 (0.41) TLR8TLR7STK17ASTK17BL3MBTL1
SCHEMBL23472263 0.84 S1PR4 (0.47) STK17AMEN1KMT2AALDH1A1HPGD
SCHEMBL23472323 0.84 TLR8 (0.54) TLR8TLR7ALDH1A1
SCHEMBL23472190 0.84 TLR7 (0.41) TLR8TLR7STK17ASTK17BALDH1A1
SCHEMBL20219583 0.81 TLR8 (0.44) TLR8TLR7STK17ASTK17BKDM4E
SCHEMBL23472288 0.81 TLR8 (0.38) TLR8TLR7KDM4ESMN1; SMN2CRHR1
SCHEMBL23472163 0.81 TLR7 (0.49) TLR8TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3330257-A1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS Janssen Sciences Ireland UC (IE) 2018-06-06 — — EP disclosed
Send feedback